EUVIMEDEUVIMED entdecken
BeobachtungsstudieOpen Access · CC BY 4.0

Changes in Peak Inspiratory Flow After Acute Bronchodilation: An Observational Study of Patients with Stable Chronic Obstructive Pulmonary Disease

Roy A Pleasants iD, Asif Shaikh, Ashley G Henderson, Valentina Bayer, M Bradley Drummond

Journal of Aerosol Medicine and Pulmonary Drug Delivery · 01.08.2024 · 37 (4) · 171-179

DOI: 10.1089/jamp.2023.0045 ↗

Kurz gefasst

Beobachtungsstudie in der Zeitschrift Journal of Aerosol Medicine and Pulmonary Drug Delivery, online erschienen am 29.05.2024. Verfasst von Roy A Pleasants und 4 weiteren Autor:innen. Beteiligte Einrichtung: Marsico Lung Institute, University of North Carolina at Chapel Hill, Chapel Hill, North Carolina, USA. Hauptthemen laut MEDLINE: Pulmonary Disease, Chronic Obstructive, Bronchodilator Agents, Albuterol, Dry Powder Inhalers. Die Arbeit wurde bisher 3-mal zitiert (Crossref) und nennt 45 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0).

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Introduction

Identifying factors influencing peak inspiratory flow (PIF) is essential for aerosol drug delivery in stable patients with chronic obstructive pulmonary disease. While a minimum PIF for dry powder inhalers (DPIs) is established, acute bronchodilator (BD) effects on PIF remain unknown. Materials and Methods: An inspiratory flow meter (In-Check™ DIAL) was used to measure PIF in stable patients during a 24-week observational cross-sectional study. Additionally, bronchodilator responsiveness (BDR) was determined using the In-Check DIAL device and spirometry. Patients received four puffs of albuterol, and pre- and post-BD PIF, forced expiratory volume in one second (FEV 1 ), and forced vital capacity were measured. Sixty-three patients completed acute BDR data collection from July 31, 2019, to November 9, 2021. Primary endpoints were pre- and post-BD spirometry and PIF. Statistical analyses included PIF correlations with FEV 1 . BD change was assessed according to inhaler resistance and sex (subgroup analysis).

Results

Median patient age was 64.8 years, 85.7% were non-Hispanic White, and 57.1% were female. The median increase in absolute PIF (In-Check DIAL) was 5.0 L/min, and the % PIF change was 8.9%. With albuterol, 57.1% experienced a PIF BD change >5.0%, whereas 49.2% experienced a change >10.0%. Similarly, 55.6% experienced an FEV 1 BD change >5.0% and 28.6% had a >10.0% FEV 1 BD change with albuterol. PIF was weakly correlated with FEV 1 BD change (absolute; % PIF; r = 0.28 [ p = 0.02]; r = 0.21 [ p = 0.11]). Pre- and post-BD median PIF were 75.5 and 83.5 L/min for low-to-medium–resistance DPI and 45.0 and 52.0 L/min for high-resistance, respectively. The median increases in pre- and post-BD PIF were 9.0 L/min in males and 4.5 L/min in females. In contrast to when using the In-Check DIAL device, we observed no consistent bronchodilatory effects on PIF measured by spirometry.

Conclusions

Using the In-Check DIAL device, ∼50% of patients experienced >10% PIF increase after acute BD, potentially enhancing medication lung deposition. Further research is required to understand PIF's impact on medication delivery. ClinicalTrials.gov Identifier: NCT04168775

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Pulmonary Disease, Chronic ObstructiveBronchodilator AgentsAlbuterolDry Powder InhalersSpirometryHumansMaleFemaleMiddle AgedAgedCross-Sectional StudiesAdministration, InhalationForced Expiratory VolumeAerosolsVital CapacityInhalation

Stichwörter der Autor:innen

In-Check DIALbronchodilatorbronchodilator responsivenesschronic obstructive pulmonary diseasedry powder inhalerpeak inspiratory flow

Substanzen

Bronchodilator AgentsAlbuterolAerosols

Autor:innen und Institutionen

  • Marsico Lung Institute, University of North Carolina at Chapel Hill, Chapel Hill, North Carolina, USA.
  • Division of Pulmonary and Critical Care Medicine, University of Michigan, Ann Arbor, Michigan, USA.
  • Boehringer Ingelheim Pharmaceuticals, Inc., Ridgefield, Connecticut, USA.
  • Division of Pulmonary Diseases and Critical Care Medicine, University of North Carolina at Chapel Hill, Chapel Hill, North Carolina, USA.

ORCID-Profile: Roy A Pleasants

Zitieren

APA

Pleasants, R. A., Shaikh, A., Henderson, A. G., Bayer, V., & Drummond, M. B. (2024). Changes in Peak Inspiratory Flow After Acute Bronchodilation: An Observational Study of Patients with Stable Chronic Obstructive Pulmonary Disease. Journal of Aerosol Medicine and Pulmonary Drug Delivery, 37(4), 171-179. https://doi.org/10.1089/jamp.2023.0045

Vancouver

Pleasants RA, Shaikh A, Henderson AG, Bayer V, Drummond MB. Changes in Peak Inspiratory Flow After Acute Bronchodilation: An Observational Study of Patients with Stable Chronic Obstructive Pulmonary Disease. Journal of Aerosol Medicine and Pulmonary Drug Delivery. 2024;37(4):171-179. doi:10.1089/jamp.2023.0045

BibTeX
@article{Pleasants2024,
  author = {Pleasants, Roy A and Shaikh, Asif and Henderson, Ashley G and Bayer, Valentina and Drummond, M Bradley},
  title = {Changes in Peak Inspiratory Flow After Acute Bronchodilation: An Observational Study of Patients with Stable Chronic Obstructive Pulmonary Disease},
  journal = {Journal of Aerosol Medicine and Pulmonary Drug Delivery},
  year = {2024},
  volume = {37},
  number = {4},
  pages = {171--179},
  doi = {10.1089/jamp.2023.0045}
}
Kostenlos starten →